BEAM

Beam Therapeutics Inc.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1745999Held by 4 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

4 managers · Q2 2026 13F

13F bookWeight

ARK Investment Management

ARK Investment ManagementPosition history →

2.3%

(15.6%)

$351.3M

$15.40B13F book · 2026-06-30

Yiheng Capital

Yiheng CapitalPosition history →

0.31%

—

$0.7M

$0.23B13F book · 2026-06-30

Duquesne Family Office

Stanley DruckenmillerPosition history →

0.12%

NEW

$5.3M

$4.35B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.02%

(13.4%)

$15.3M

$72.62B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.